
- Telehealth Visits
- Insurance plan information

Austin N. Angelidakis, NP
He | Him | HisGenitourinary Medical Oncology- Telehealth Visits
- Insurance plan information



Austin N. Angelidakis, NP
He | Him | HisGenitourinary Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Austin N. Angelidakis cares for patients with genital or urinary organ cancers, including kidney, bladder, testicular and prostate cancers. He seeks to help patients understand all aspects of their care and to treat them holistically, using a shared decision-making approach.
Angelidakis contributes to research investigating new therapies for genitourinary cancers.
A native of the Bay Area, Angelidakis earned a bachelor's degree in biological sciences in Southern California, at the University of California, Irvine, then worked for several years at UCSF in health care administration and breast oncology research. He furthered his pre-health education through Johns Hopkins University before earning his bachelor's and master's degrees in nursing science from the University of Pennsylvania, where he specialized in adult oncology. He contributed to research in oncology genetics at Penn Medicine's Abramson Cancer Center.
Education & training
Board certification
- Adult-Gerontology Primary Care NP, American Nurses Credentialing Center
Degree
- NP, University of Pennsylvania School of Nursing
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224151%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224151%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.